Application

OKPERLA

Beigene, Ltd.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97271338
Filing Date: 02/17/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97271338
MARK INFORMATION
*MARK OKPERLA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT OKPERLA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Beigene, Ltd.
INTERNAL ADDRESS c/o Mourant Ozannes Corporate Services
*MAILING ADDRESS 94 Solaris Ave, Camana Bay
*CITY Grand Cayman
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Cayman Islands
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
KY1-1108
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE limited company (ltd.)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Cayman Islands
OWNER DOMICILE ADDRESS(NEW)
*ADDRESS XXXX
*CITY XXXX
*STATE
(Required for U.S. applicants)
XXXX
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY XXXX
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
XXXX
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases.
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Kristen S. Ruisi
ATTORNEY DOCKET NUMBER 140679559195
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Venable LLP
INTERNAL ADDRESS Rockefeller Center
STREET 1270 Avenue of the Americas, 24th Fl., R
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10020
PHONE 212-503-0559
FAX 212-307-5598
EMAIL ADDRESS KSRuisi@venable.com
CORRESPONDENCE INFORMATION
NAME Kristen S. Ruisi
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE KSRuisi@venable.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NYIPDocketing@venable.com; khamilton-odoh@venable.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /David Carpenter/
SIGNATORY'S NAME David Carpenter
SIGNATORY'S POSITION Senior Director, IP Counsel
SIGNATORY'S PHONE NUMBER 628-239-0985
DATE SIGNED 02/16/2022
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97271338
Filing Date: 02/17/2022

To the Commissioner for Trademarks:

MARK: OKPERLA (Standard Characters, see mark)
The literal element of the mark consists of OKPERLA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Beigene, Ltd., a limited company (ltd.) legally organized under the laws of Cayman Islands, having an address of
      c/o Mourant Ozannes Corporate Services
      94 Solaris Ave, Camana Bay
      Grand Cayman KY1-1108
      Cayman Islands
      XXXX
Beigene, Ltd., having a domicile address of:

      XXXX
      XXXX, XXXX XXXX
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Kristen S. Ruisi. Kristen S. Ruisi of Venable LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      Rockefeller Center
      1270 Avenue of the Americas, 24th Fl., R
      New York, New York 10020
      United States
      212-503-0559(phone)
      212-307-5598(fax)
      KSRuisi@venable.com
The docket/reference number is 140679559195.
Kristen S. Ruisi submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Kristen S. Ruisi
       PRIMARY EMAIL FOR CORRESPONDENCE: KSRuisi@venable.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NYIPDocketing@venable.com; khamilton-odoh@venable.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /David Carpenter/   Date: 02/16/2022
Signatory's Name: David Carpenter
Signatory's Position: Senior Director, IP Counsel
Signatory's Phone Number: 628-239-0985
Signature method: Sent to third party for signature
Payment Sale Number: 97271338
Payment Accounting Date: 02/17/2022

Serial Number: 97271338
Internet Transmission Date: Thu Feb 17 10:51:57 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-202202171051573
72580-97271338-810eaf55b487666d122cf1649
ad58b82ae194ff562fb7ac1bbb1ecfaa8d92fa68
-CC-51564013-20220216131452262589

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed